The new managing Director of Aptys Pharma is Bernard van Iseghem
Aptys Pharma is pleased to announce the appointment of Bernard van Iseghem as Managing Director Group from the 1st of September 2021.
Read morePaper published in “European Journal of Pain”
Synergism between oral paracetamol and nefopam in a murine model of postoperative pain
Read moreMetapain®
Metapain®: treatment of the first patients in the phase 3 clinical study in France.
Read moreAptys pharmaservices
The branch Aptys Pharmaservices successfully passed a regulatory inspection of Good Manufacturing Practices (GMP) by the French agency ANSM.
Read more